caa a22 4500 445315016 CHVBK 20180317142643.0 cr unu---uuuuu 170323e20110701xx s 000 0 eng 10.1007/s10552-011-9776-x doi (NATIONALLICENCE)springer-10.1007/s10552-011-9776-x Giovannucci Edward Departments of Nutrition and Epidemiology, Harvard School of Public Health, 665 Huntington Avenue, 02136, Boston, MA, USA aut Commentary: Serum lycopene and prostate cancer progression: a re-consideration of findings from the prostate cancer prevention trial [Elektronische Daten] [Edward Giovannucci] A recent analysis in the Prostate Cancer Prevention Trial (PCPT) appeared to show no association between serum lycopene and prostate cancer risk, but the unique study design of the PCPT and the complexity of prostate cancer epidemiology suggest an alternative interpretation of the reported findings. Springer Science+Business Media B.V., 2011 Prostate cancer nationallicence Lycopene nationallicence PSA screening nationallicence Cancer Causes & Control Springer Netherlands 22/7(2011-07-01), 1055-1059 0957-5243 22:7<1055 2011 22 10552 https://doi.org/10.1007/s10552-011-9776-x text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s10552-011-9776-x text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Giovannucci Edward Departments of Nutrition and Epidemiology, Harvard School of Public Health, 665 Huntington Avenue, 02136, Boston, MA, USA aut NATIONALLICENCE 773 0- Cancer Causes & Control Springer Netherlands 22/7(2011-07-01), 1055-1059 0957-5243 22:7<1055 2011 22 10552 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer